152 related articles for article (PubMed ID: 3080822)
21. [Autoradiographic studies on the protective effect of mesna in the urinary bladder mucosa of the rat during administration of cyclophosphamide (preliminary communication)].
Kunze E; Köhnecke B; Engelhardt W; Brock N; Pohl J
Arzneimittelforschung; 1983; 33(6):853-4. PubMed ID: 6412725
[TBL] [Abstract][Full Text] [Related]
22. L-Carnitine Protect against Cyclophosphamide Induced Skeletal and Neural Tube Malformations in Rat Fetuses.
Khaksary Mahabady M; Najafzadeh Varzi H; Zareyan Jahromi S
Acta Med Iran; 2015 Nov; 53(11):703-10. PubMed ID: 26786992
[TBL] [Abstract][Full Text] [Related]
23. The use of sodium 2-mercaptoethane sulfonate to prevent cyclophosphamide cystitis.
Ehrlich RM; Freedman A; Goldsobel AB; Stiehm ER
J Urol; 1984 May; 131(5):960-2. PubMed ID: 6423841
[TBL] [Abstract][Full Text] [Related]
24. Relative mutagenicity and teratogenicity of cyclophosphamide and two of its structural analogs.
Hales BF
Biochem Pharmacol; 1983 Dec; 32(24):3791-5. PubMed ID: 6362674
[TBL] [Abstract][Full Text] [Related]
25. The efficacy of mesna (2-mercaptoethane sodium sulfonate) as a uroprotectant in patients with hemorrhagic cystitis receiving further oxazaphosphorine chemotherapy.
Andriole GL; Sandlund JT; Miser JS; Arasi V; Linehan M; Magrath IT
J Clin Oncol; 1987 May; 5(5):799-803. PubMed ID: 3106585
[TBL] [Abstract][Full Text] [Related]
26. [Effects of mesna (2-mercaptoethane sodium sulfonate) in children with malignant disease receiving oxazaphosphorine chemotherapy].
Iwasaku-Fujimoto M; Fujiwara F; Todo S; Morioka Y; Imashuku S
Gan To Kagaku Ryoho; 1990 Mar; 17(3 Pt 1):403-6. PubMed ID: 2106836
[TBL] [Abstract][Full Text] [Related]
27. Detoxification of urotoxic oxazaphosphorines by sulfhydryl compounds.
Brock N; Pohl J; Stekar J
J Cancer Res Clin Oncol; 1981; 100(3):311-20. PubMed ID: 6792207
[TBL] [Abstract][Full Text] [Related]
28. Prevention of urotoxic side effects by regional detoxification with increased selectivity of oxazaphosphorine cytostatics.
Brock N; Pohl J
IARC Sci Publ; 1986; (78):269-79. PubMed ID: 3108156
[TBL] [Abstract][Full Text] [Related]
29. Attenuation of cytogenetic damage by 2-mercaptoethanesulfonate in cultured human lymphocytes exposed to cyclophosphamide and its reactive metabolites.
Wilmer JL; Erexson GL; Kligerman AD
Cancer Res; 1986 Jan; 46(1):203-10. PubMed ID: 3079586
[TBL] [Abstract][Full Text] [Related]
30. Delayed development of bladder cancer in male SD rats induced with N-nitroso-N-butyl-N-(4-hydroxybutyl)amine following concomitant administration of sodium 2-mercaptoethane sulfonate.
Berger MR; Schmähl D
Cancer Lett; 1986 Sep; 32(3):313-21. PubMed ID: 3094932
[TBL] [Abstract][Full Text] [Related]
31. Lack of effects of sodium 2-mercaptoethane sulfonate (mesna) on Ochratoxin A induced renal tumorigenicity following life-time oral administration of Ochratoxin A in DA and Lewis rats.
Son WC; Kamino K; Lee YS; Kang KS
Toxicol Lett; 2003 Apr; 142(1-2):19-27. PubMed ID: 12765235
[TBL] [Abstract][Full Text] [Related]
32. Green tea extract increases cyclophosphamide-induced teratogenesis by modulating the expression of cytochrome P-450 mRNA.
Park D; Jeon JH; Shin S; Joo SS; Kang DH; Moon SH; Jang MJ; Cho YM; Kim JW; Ji HJ; Ahn B; Oh KW; Kim YB
Reprod Toxicol; 2009 Jan; 27(1):79-84. PubMed ID: 19103281
[TBL] [Abstract][Full Text] [Related]
33. Prevention of cyclophosphamide-induced carcinogenesis in the urinary bladder of rats by administration of mesna.
Schmähl D; Habs MR
Cancer Treat Rev; 1983 Sep; 10 Suppl A():57-61. PubMed ID: 6414697
[No Abstract] [Full Text] [Related]
34. Teratogenic effects of nitrazepam in rats.
Takeno S; Nakagawa M; Sakai T
Res Commun Chem Pathol Pharmacol; 1990 Jul; 69(1):59-70. PubMed ID: 2218071
[TBL] [Abstract][Full Text] [Related]
35. Teratogenicity of 2-ethoxyethanol by dermal application.
Hardin BD; Niemeier RW; Smith RJ; Kuczuk MH; Mathinos PR; Weaver TF
Drug Chem Toxicol; 1982; 5(3):277-94. PubMed ID: 7151721
[TBL] [Abstract][Full Text] [Related]
36. Transplacental teratogenesis and mutagenesis in mouse fetuses treated with cyclophosphamide.
Porter AJ; Singh SM
Teratog Carcinog Mutagen; 1988; 8(4):191-203. PubMed ID: 2906177
[TBL] [Abstract][Full Text] [Related]
37. Embryocidal, teratogenic and fetotoxic effects of citrinin in rats.
Reddy RV; Mayura K; Hayes AW; Berndt WO
Toxicology; 1982; 25(2-3):151-60. PubMed ID: 7157396
[TBL] [Abstract][Full Text] [Related]
38. Bioavailability of orally administered mesna.
Burkert H; Lücker PW; Wetzelsberger N; Breuel HP
Arzneimittelforschung; 1984; 34(11):1597-600. PubMed ID: 6441581
[TBL] [Abstract][Full Text] [Related]
39. Cytogenetic testing of mutagenic and radioprotective effects of mesna.
Becher R; Kakati S; Gibas Z; Sandberg AA
Oncology; 1983; 40(4):287-9. PubMed ID: 6408550
[TBL] [Abstract][Full Text] [Related]
40. Embryocidal, fetotoxic and teratogenic effects of ochratoxin A in rats.
Mayura K; Reddy RV; Hayes AW; Berndt WO
Toxicology; 1982; 25(2-3):175-85. PubMed ID: 7157398
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
